Brief: Avenira Says Strategic Investment From Sichuan Hebang Biotechnology

Avenira

30/07/2024 11:27

July 30 (Reuters) - Avenira Ltd  AEV.AX :
    * STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY
    * INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT
ISSUE
PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS
    * AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT
EXECUTIVE
CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM
    * FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG
AS
EXECUTIVE CHAIRMAN AND CEO


Further company coverage:  AEV.AX 

 ((Reuters.Briefs@thomsonreuters.com;))